Literature DB >> 10094816

Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells.

S L Hsu1, M C Chen, Y H Chou, G Y Hwang, S C Yin.   

Abstract

The biological activity of retinoic acid (RA) was examined in human hepatoma Hep3B cells. Under serum-deprived conditions, RA induced S/M-phase elevation and mitotic index increase within 24 h, followed by apoptosis. This RA-induced apoptosis was accompanied by p53-independent up-regulation of endogenous p21(CIPI/Waf1) and Bax proteins, as well as activation of p34(cdc2) kinase, and increase of Rb2 protein level and phosphorylation pattern. In addition, RA had no effect on the levels of Bcl-XL; Bcl-XS; cyclins A, B, D1, D3, or E; or Rb1 expression but markedly down-modulated Cdk2 kinase activity and reduced Cdk4 expression. RA also slightly delayed p27(Kip1) expression. Olomoucine, a potent p34(cdc2) and Cdk2 inhibitor, effectively blocked RA-mediated p34(cdc2) kinase activation and prevented RA-induced apoptosis. Furthermore, antisense oligonucleotide complementary to p21(CIP2/Waf1) and p34(cdc2) mRNA significantly rescued RA-induced apoptosis. Our data indicate that p21(CIP2/Waf1) overexpression may not be the only regulatory factor necessary for RA-induced apoptosis in human hepatoma Hep3B cells. RA treatment leads to Rb2 hyperphosphorylation, and p34(cdc2) kinase activation is coincident with an aberrant mitotic progression, followed by appearance of abnormal nucleus. This aberrant cell cycle progression appeared requisite for RA-induced cell death. These findings suggest that inappropriate regulation of the cell cycle regulators p21(CIP2/Waf1) and p34(cdc2) is coupled with induction of Bax and involved in cell death with apoptosis when Hep3B cells are exposed to RA. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094816     DOI: 10.1006/excr.1999.4397

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis.

Authors:  Y Y Hsieh; F J Tsai; C C Chang; W C Chen; C H Tsai; H D Tsai; C C Lin
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Effects of retinoic acid on proliferation, phenotype and expression of cyclin-dependent kinase inhibitors in TGF-beta1-stimulated rat hepatic stellate cells.

Authors:  Guang-Cun Huang; Jin-Sheng Zhang; Yue-E Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Induction of retinoid X receptor activity and consequent upregulation of p21WAF1/CIP1 by indenoisoquinolines in MCF7 cells.

Authors:  Eun-Jung Park; Tamara P Kondratyuk; Andrew Morrell; Evgeny Kiselev; Martin Conda-Sheridan; Mark Cushman; Soyoun Ahn; Yongsoo Choi; Jerry J White; Richard B van Breemen; John M Pezzuto
Journal:  Cancer Prev Res (Phila)       Date:  2011-04

4.  Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner.

Authors:  Annapina Russo; Davide Esposito; Morena Catillo; Concetta Pietropaolo; Elvira Crescenzi; Giulia Russo
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

5.  Role of the translational repressor 4E-BP1 in the regulation of p21(Waf1/Cip1) expression by retinoids.

Authors:  Padma Kannan-Thulasiraman; Blazej Dolniak; Surinder Kaur; Antonella Sassano; Dhananjaya V Kalvakolanu; Nissim Hay; Leonidas C Platanias
Journal:  Biochem Biophys Res Commun       Date:  2008-02-15       Impact factor: 3.575

6.  An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.

Authors:  Fumihiko Kanai; Shuntaro Obi; Shigetoshi Fujiyama; Shuichiro Shiina; Hideyuki Tamai; Hitoshi Mochizuki; Yukihiro Koike; Jun Imamura; Takayoshi Yamaguchi; Isamu Saida; Osamu Yokosuka; Masao Omata
Journal:  Hepatol Int       Date:  2013-07-25       Impact factor: 9.029

7.  Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21.

Authors:  G He; J Kuang; Z Huang; J Koomen; R Kobayashi; A R Khokhar; Z H Siddik
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

8.  Retinoic acid and cancer treatment.

Authors:  Mei-Chih Chen; Shih-Lan Hsu; Ho Lin; Tsung-Ying Yang
Journal:  Biomedicine (Taipei)       Date:  2014-11-28

Review 9.  Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.

Authors:  Muhammet Oner; Eugene Lin; Mei-Chih Chen; Fu-Ning Hsu; G M Shazzad Hossain Prince; Kun-Yuan Chiu; Chieh-Lin Jerry Teng; Tsung-Ying Yang; Hsin-Yi Wang; Chia-Herng Yue; Ching-Han Yu; Chih-Ho Lai; Jer-Tsong Hsieh; Ho Lin
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

10.  Retinoic Acid Induces Apoptosis of Prostate Cancer DU145 Cells through Cdk5 Overactivation.

Authors:  Mei-Chih Chen; Chih-Yang Huang; Shih-Lan Hsu; Eugene Lin; Chien-Te Ku; Ho Lin; Chuan-Mu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-13       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.